Considering the fact that teduglutide targets barrier function of the gut and available IBD therapies target mainly immune and inflammatory pathways, new studies should focus on determination whether administration of teduglutide would allow to decrease a dose of corticosteroids or biologics in IBD patients (Blonski et al
Benefits versus risks (side effects, long-term use)
For this reason, the .75 mg injection is typically viewed as a transitional dose during titration rather than a target maintenance dose
Did you know GLP-1 agonists can: Reduce inflammation, Support brain function, Treat Alzheimers, dementia, and various autoimmune disorders, Enhance metabolic health, AND of course combat weight gain
Because these medications influence multiple metabolic pathways, thoughtful preparation helps ensure that your experience is comfortable, your dosing is safe, and your treatment plan is aligned with your goals